Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

201 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Trends in Volumes and Survival After Hematopoietic Cell Transplantation in Racial/Ethnic Minorities.
Khera N, Ailawadhi S, Brazauskas R, Patel J, Jacobs B, Ustun C, Ballen K, Abid MB, Díaz MA, Al-Homsi AS, Hashem H, Hong S, Munker R, Schears R, Lazarus HM, Ciurea SO, Badawy SM, Savani BN, Wirk B, LeMaistre CF, Bhatt NS, Beitinjaneh A, Aljurf M, Sharma A, Cerny J, Knight JM, Kelkar AH, Yared JA, Kindwall-Keller T, Winestone LE, Steinberg A, Arnold SD, Seo S, Preussler JM, Hossain NM, Fingrut WB, Agrawal V, Hashmi S, Lehmann LE, Wood WA, Rangarajan HG, Saber W, Hahn T. Khera N, et al. Among authors: ailawadhi s. Blood Adv. 2024 Apr 25:bloodadvances.2023012469. doi: 10.1182/bloodadvances.2023012469. Online ahead of print. Blood Adv. 2024. PMID: 38661372
Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: a SEER-medicare analysis.
Ailawadhi S, Frank RD, Advani P, Swaika A, Temkit M, Menghani R, Sharma M, Meghji Z, Paulus S, Khera N, Hashmi SK, Paulus A, Kakar TS, Hodge DO, Colibaseanu DT, Vizzini MR, Roy V, Colon-Otero G, Chanan-Khan AA. Ailawadhi S, et al. Cancer Med. 2017 Dec;6(12):2876-2885. doi: 10.1002/cam4.1246. Epub 2017 Nov 3. Cancer Med. 2017. PMID: 29105343 Free PMC article.
Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparities.
Ailawadhi S, Frank RD, Sharma M, Menghani R, Temkit M, Paulus S, Khera N, Hashmi S, Advani P, Swaika A, Paulus A, Aslam N, Sher T, Roy V, Colon-Otero G, Chanan-Khan A. Ailawadhi S, et al. Cancer. 2018 Apr 15;124(8):1710-1721. doi: 10.1002/cncr.31237. Epub 2018 Jan 23. Cancer. 2018. PMID: 29360160 Free article.
Multiple Myeloma: Current Clinical Landscape and Compounding Costs.
Beck K, Sandahl T, Ailawadhi S, Khera N, Jensen C. Beck K, et al. Among authors: ailawadhi s. Curr Hematol Malig Rep. 2023 Oct;18(5):201-215. doi: 10.1007/s11899-023-00705-8. Epub 2023 Jul 21. Curr Hematol Malig Rep. 2023. PMID: 37477783 Review.
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed lenalidomide-refractory multiple myeloma.
Paludo J, Mikhael JR, LaPlant BR, Halvorson AE, Kumar S, Gertz MA, Hayman SR, Buadi FK, Dispenzieri A, Lust JA, Kapoor P, Leung N, Russell SJ, Dingli D, Go RS, Lin Y, Gonsalves WI, Fonseca R, Bergsagel PL, Roy V, Sher T, Chanan-Khan AA, Ailawadhi S, Stewart AK, Reeder CB, Richardson PG, Rajkumar SV, Lacy MQ. Paludo J, et al. Among authors: ailawadhi s. Blood. 2017 Sep 7;130(10):1198-1204. doi: 10.1182/blood-2017-05-782961. Epub 2017 Jul 6. Blood. 2017. PMID: 28684537 Free PMC article. Clinical Trial.
201 results